A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma

Clinical trial NCT02792803 · UNKNOWN

Trial details

NCT number: NCT02792803
Sponsor: Dr. David Yan
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

POAG Primary Open Angle Glaucoma Ocular Hypertension

Start date: 2015-09-01
Primary completion: 2017-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.